newsfilter
← Latest News
Business Wire·

Puma Biotechnology Reports Third Quarter 2025 Financial Results

Raising 2025 NERLYNX® revenue and net income estimates Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2025. Unless